^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Thyroid Gland Medullary Carcinoma |
| Drug: | Cabometyx (cabozantinib tablet) (Multi-tyrosine kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Medullary Thyroid Carcinoma...Vandetanib and cabozantinib, oral kinase inhibitors, are recommended for the treatment of medullary carcinoma in patients with unresectable locally advanced or metastatic disease…
